Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239
Authors
Anton M. Jetten (ORCID: https://orcid.org/0000-0003-0954-4445)
Vijay K. Boda (ORCID: https://orcid.org/0000-0001-7299-2369)
Sivani B. Reddy (ORCID: https://orcid.org/0000-0001-9948-2334)
Robert C. Tuckey (ORCID: https://orcid.org/0000-0002-5022-4729)
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239
Anton M. Jetten, Vijay K. Boda, Sivani B. Reddy, Robert C. Tuckey et al.
Journal
Cells
Topics
Vitamin D Research Studies
article
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239
Anton M. Jetten, Vijay K. Boda, Sivani B. Reddy, Robert C. Tuckey, Shariq Qayyum, Justyna Szpotan, Zorica Janjetović, Ewa Podgorska, Senthilkumar Ravichandran, Andrzej T. Slominski, S. Gates Scott, Alisa A. Mobley, Wei Li
article en
Abstract
No abstract available for this paper.
Publication Tag
CellsVol. 15(7)
Institutions
Brigham and Women's Hospital (US), National Institutes of Health (US), Harvard University (US), University of Tennessee Health Science Center (US), The University of Western Australia (AU), University of Alabama at Birmingham (US), National Institute of Environmental Health Sciences (US), Birmingham VA Medical Center (US)
Funders
U.S. Department of Defense, National Institutes of Health